About MabPlex
MabPlex is a company based in Yantai (China) founded in 2013.. MabPlex has raised $130 million across 2 funding rounds from investors including Orbimed, Sunshine Insurance Group and Detong Capital. MabPlex offers products and services including CDMO Services, Research Development, and GMP Manufacturing. MabPlex operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and ProBioGen AG, among others.
- Headquarter Yantai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mabplex International Co. Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$130 M (USD)
in 2 rounds
-
Latest Funding Round
$71 M (USD), Series B
Jun 08, 2020
-
Investors
Orbimed
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MabPlex
MabPlex offers a comprehensive portfolio of products and services, including CDMO Services, Research Development, and GMP Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers contract services for biologics research and production
Provides development support for biopharmaceutical innovations
Delivers compliant manufacturing for biologics and ADCs
Funding Insights of MabPlex
MabPlex has successfully raised a total of $130M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $71 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $71.0M
-
First Round
First Round
(21 Jan 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series B - MabPlex | Valuation | Detong Capital , Huajin Capital | |
| Jan, 2019 | Amount | Series A - MabPlex | Valuation | Shenzhen Capital Group , SDIC Venture Capital Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MabPlex
MabPlex has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Sunshine Insurance Group and Detong Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MabPlex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MabPlex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mabplex Comparisons
Competitors of MabPlex
MabPlex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and ProBioGen AG, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Mammalian cell culture biologics are developed through contract research services.
|
|
| domain | founded_year | HQ Location |
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
|
| domain | founded_year | HQ Location |
Contract manufacturing solutions for biologics are provided to Asian companies.
|
|
| domain | founded_year | HQ Location |
Drug substance development, analytical, and compliance services are provided.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mabplex
Frequently Asked Questions about MabPlex
When was MabPlex founded?
MabPlex was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Where is MabPlex located?
MabPlex is headquartered in Yantai, China. It is registered at Yantai, Shandong, China.
Is MabPlex a funded company?
MabPlex is a funded company, having raised a total of $130M across 2 funding rounds to date. The company's 1st funding round was a Series A of $59M, raised on Jan 21, 2019.
What does MabPlex do?
MabPlex was established in 2013 as a contract development and manufacturing organization based in Yantai, China. Focus is placed on biologics, including antibody-drug conjugates, mammalian cell-line derived active pharmaceutical ingredients, and monoclonal antibodies. Services encompass cell banking, protein characterization, formulation, lyophilization, fill-finish operations, and final packaging. Quality assurance, control, and regulatory support are provided, with compliance to FDA, EMA, and CFDA standards maintained.
Who are the top competitors of MabPlex?
MabPlex's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
What products or services does MabPlex offer?
MabPlex offers CDMO Services, Research Development, and GMP Manufacturing.
Who are MabPlex's investors?
MabPlex has 10 investors. Key investors include Orbimed, Sunshine Insurance Group, Detong Capital, CMS China, and Huayao Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.